• Innovative biotechnology company

    focused on the discovery and the development of biopharmaceuticals to provide innovative therapies in hepatology and oncology disorders

    Mission & Strategy 
  • Founded in 2006

    by two hepato-gastro-enterologists, with the idea of bringing new therapeutic perspective for the treatment of liver diseases

    History & Funding 
  • Strong collaborative research

    with its historical partner Inserm-Paris XI unit 785.

    Collaborative research 

1 2 3

Products

ALF-5755 for the treatment of acute liver failure and severe acute hepatitis

Learn more +
 

News & Press

Learn more +